The growing morbidity, mortality, and health care costs related to heart failure (HF) underscore the urgent need to ...

Participants who walked faster were more likely to be men, live in less deprived areas, have healthier lifestyles and weigh ...

Bristol Myers Squibb's drug to treat a type of heart disease did not significantly improve functional capacity and symptoms ...

Cardiovascular disease remains a leading cause of morbidity and mortality in adults despite recent scientific advancements. Although people are living longer lives, there may be an adverse impact on ...

Dr. Evan Levine tackles a drug that is often prescribed to help children perform better — a phenomenon he calls “borderline ...

An international team of researchers at the University of Manchester, Baylor College of Medicine and collaborating ...

A retrospective analysis from Israel suggested that markers of poor hydration are linked to increased risks of hypertension ...

The total costs to care for adult patients with heart failure will increase to $142 billion annually by 2050, according to a scientific statement published April 16 by the American Heart Association ...

Finerenone prevented new-onset atrial fibrillation or flutter in patients with chronic kidney disease and type 2 diabetes or ...

Preventing Onset and Development of Heart Failure With Preserved Ejection Fraction Apr. 15, 2025 — An international team of researchers has discovered a natural mechanism that protects the heart ...

Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can ...